Article · 10 Feb 2026
OpinionPublished 14 Sep 2021
New Treatment Options for Lung Cancer
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Non-small cell lung cancer (NSCLC) accounts for around 27% of all cancer-related deaths worldwide, making it a major public health concern. Healing necessitates the complete and permanent removal of the tumour (generally by surgery or radiation [RT]), while significant shrinkage (usually by systemic therapy) may result in long-term disease control. In the absence of treatments, host-tumor interactions, which are major factors in disease progression in the natural history, will have a considerable impact on disease progression, with treatments primarily aiming at shifting the host-tumor balance toward improvement or, if possible, healing. As a result, complete tumoral excision (and, if possible, oligometastatic sickness) remains the preferred treatment, with the goal that the host-immune response will remove microscopic residual disease, maybe with the help of systemic adjuvant medicines.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Molecular Histology & Medical Physiology.
Brief report · 29 Nov 2025
Engineered Tissues: Mimicking and Advancing Biomedical Research
Commentary · 29 Nov 2025
Molecular Microdesign: Control, Imaging, and Biological Systems
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Molecular Histology & Medical Physiology
- SubjectGenetics & Molecular Biology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “George Brown”
